Executive Board
The Executive Board (EB) is appointed by the Supervisory Board and consists of seven members drawn from the various "blood groups" that make up TI Pharma.
Representing large industrial partners:
- A.W.M. Rijnders, Ph.D., Vice President Research, Schering-Plough
- Professor J.A.M. Raaijmakers, Ph.D., Vice President External Scientific Collaborations Europe, GlaxoSmithKline Pharmaceuticals
Representing small- and medium-sized industrial partners:
- J.B.M.M. van Bree, Ph.D., Chief Executive Officer, Pepscan
- R. Lageveen, Ph.D., Chief Executive Officer of IQ Corporation
Representing academic partners:
- Professor L.F.M.H. de Leij, Ph.D., Head of the department of Medical Biology and Dean University Medical Center Groningen
- R.M. Smit, Ph.D., Chairman of the Executive Board, VU University Amsterdam
- Professor M. Danhof, Ph.D., Professor of Pharmacology and Director of Research, Leiden/Amsterdam Center for Drug Research